A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma
Clinical trial NCT04977193 · UNKNOWN
Trial details
- NCT number
- NCT04977193
- Sponsor
- Shanghai Longyao Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2023-05-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.